T cell immunopathogenesis and immunotherapeutic strategies for chronic hepatitis B virus infection

被引:40
|
作者
Shimizu, Yukihiro [1 ]
机构
[1] Takaoka City Hosp, Gastroenterol Unit, Takaoka, Toyama 9338550, Japan
关键词
T cells; Immunopathogenesis; Immunotherapy; Hepatitis B virus infection; COLONY-STIMULATING FACTOR; CHRONIC HBV INFECTION; TRANSGENIC MICE; COMBINATION THERAPY; THYMOSIN ALPHA-1; VIRAL-HEPATITIS; IMMUNE-RESPONSE; DENDRITIC CELLS; LAMIVUDINE TREATMENT; ANTIVIRAL THERAPY;
D O I
10.3748/wjg.v18.i20.2443
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis B is caused by the host immune response and T cells play a major role in the immunopathogenesis. More importantly, T cells not only destroy hepatocytes infected by hepatitis B virus (HBV), but also control HBV replication or eradicate HBV in a noncytolytic manner. Therefore, analysis of T cell immune response during acute and chronic HBV infection is important to develop a strategy for successful viral control, which could lead to immunotherapy for terminating persistent HBV infection. There have been many attempts at immunotherapy for chronic HBV infection, and some have shown promising results. High viral load has been shown to suppress antiviral immune responses and immunoinhibitory signals have been recently elucidated, therefore, viral suppression by nucleos(t)ide analogs, stimulation of antiviral immune response, and suppression of the immunoinhibitory signals must be combined to achieve desirable antiviral effects. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:2443 / 2451
页数:9
相关论文
共 50 条
  • [31] Therapeutic strategies for a functional cure of chronic hepatitis B virus infection
    Chang, Jinhong
    Guo, Fang
    Zhao, Xuesen
    Guo, Ju-Tao
    ACTA PHARMACEUTICA SINICA B, 2014, 4 (04) : 248 - 257
  • [32] Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
    Popotheodoridis, George V.
    Manolakopoulos, Spilios
    Dusheiko, Geoffrey
    Archimandritis, Athanasios J.
    LANCET INFECTIOUS DISEASES, 2008, 8 (03): : 167 - 178
  • [33] HEPATITIS-B VIRUS IMMUNOPATHOGENESIS
    CHISARI, FV
    FERRARI, C
    ANNUAL REVIEW OF IMMUNOLOGY, 1995, 13 : 29 - 60
  • [34] Immune Therapeutic Strategies in Chronic Hepatitis B Virus Infection: Virus or Inflammation Control?
    Bertoletti, Antonio
    Gehring, Adam J.
    PLOS PATHOGENS, 2013, 9 (12) : 1 - 4
  • [35] A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis
    Saraceni, Corey
    Birk, John
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (03) : 409 - 418
  • [36] Chronic hepatitis B virus infection
    Seto, Wai-Kay
    Lo, Ying-Ru
    Pawlotsky, Jean-Michel
    Yuen, Man-Fung
    LANCET, 2018, 392 (10161): : 2313 - 2324
  • [37] Chronic Hepatitis B Virus Infection
    McMahon, Brian J.
    MEDICAL CLINICS OF NORTH AMERICA, 2014, 98 (01) : 39 - +
  • [38] The Role of CTLA-4 in T Cell Exhaustion in Chronic Hepatitis B Virus Infection
    Apol, Asa Didriksen
    Winckelmann, Anni Assing
    Duus, Rasmus Buelow
    Bukh, Jens
    Weis, Nina
    VIRUSES-BASEL, 2023, 15 (05):
  • [39] Unlocking CD8+ T cell potential in chronic hepatitis B virus infection
    Fumagalli, Valeria
    Iannacone, Matteo
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2025, 22 (02) : 92 - 93
  • [40] CD8+T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection
    Cao, Wei
    Qiu, Zhifeng
    Zhu, Ting
    Li, Yanling
    Han, Yang
    Li, Taisheng
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (01) : 40 - 46